Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
8.93M
-
Shares change
-
-3.84K
-
Total reported value, excl. options
-
$158M
-
Value change
-
-$15.9K
-
Number of buys
-
13
-
Number of sells
-
-17
-
Price
-
$17.70
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2015
34 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q3 2015.
Ascendis Pharma A/S - ADR (ASND) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.93M shares
of 55.6M outstanding shares and own 16.06% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (1.46M shares), Visium Asset Management, LP (1.37M shares), FMR LLC (1.27M shares), RS INVESTMENT MANAGEMENT CO LLC (981K shares), VHCP Management, LLC (811K shares), JANUS CAPITAL MANAGEMENT LLC (715K shares), Longwood Capital Partners LLC (470K shares), BAKER BROS. ADVISORS LP (436K shares), Rock Springs Capital Management LP (270K shares), and Sio Capital Management, LLC (270K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.